US Patent Family Members and Approved Drugs for European Patent Office Patent: 0951551
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP0951551
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,740,522 | 2016-12-23 | denosumab | Amgen, Inc. | PROLIA |
| 7,411,050 | 2016-12-23 | denosumab | Amgen, Inc. | PROLIA |
| 7,744,886 | 2016-12-23 | denosumab | Amgen, Inc. | PROLIA |
| 8,333,963 | 2016-12-23 | denosumab | Amgen, Inc. | PROLIA |
| 8,377,690 | 2016-12-23 | denosumab | Amgen, Inc. | PROLIA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
